Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C

Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C

Background. Chronic hepatitis C(CHC) staging is important for therapeutic decision-making. Identification of noninvasive markers can provide alternatives to liver biopsy.Aim. To assess the value of APRI and FIB4 for CHC fibrosis staging in a cohort of nonselected outpatients from a referral center i...

Full description

Bibliographic Details
Main Authors: Ana Cláudia de Oliveira, Ibrahin El-Bacha, Mônica V. Vianna, Edison R. Parise
Format: Article
Language:English
Published: Elsevier 2016-05-01
Series:Annals of Hepatology
Subjects:
Chronic hepatitis C
Noninvasive serum markers
Hepatic fibrosis
Low-middle income country
Accuracy
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119306519

Similar Items

Similar Items